The copay accumulator case took yet another turn last week, with plaintiffs filing an appeal and a brief arguing that the government must enforce a recent court ruling.
In this wide-ranging interview, Bayer’s head of digital transformation Saskia Steinacker shares her top tips for implementing a genAI roadmap in commercial.
Pfizer to trim sales, R&D budgets as part of $500M more in cuts next year
Pfizer said it will wring another $500 million from legacy operating expenses, with cuts to its sales, R&D budgets bringing the total savings to $4 billion.
FTC cows Sanofi into giving up on Maze licensing deal
Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal. However, the rest of the biotech industry isn’t taking it lightly.
Pharma has little visibility into the growing area of PBM fees
Salaries have settled as the job market cooled from the boom times of 2020-2021. Weakness in a number of areas, though, suggests employers should turn up the heat.
HHS appeals circuit court’s rejection of ‘21 copay accumulator rule